242 related articles for article (PubMed ID: 8386513)
1. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
Ghosh MK; Ghosh K; Cohen JS
Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
[TBL] [Abstract][Full Text] [Related]
2. Oligodeoxynucleotide analogs as informational drugs to regulate translation.
Ghosh M; Ghosh K; Cohen JS
Nucleic Acids Symp Ser; 1991; (24):139-42. PubMed ID: 1668685
[TBL] [Abstract][Full Text] [Related]
3. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
Gao WY; Han FS; Storm C; Egan W; Cheng YC
Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism for suppression mRNA translation with antisense oligonucleotides].
Vlasov VV; Iurchenko LV
Mol Biol (Mosk); 1990; 24(5):1157-61. PubMed ID: 2290415
[TBL] [Abstract][Full Text] [Related]
5. Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats.
Geary RS; Khatsenko O; Bunker K; Crooke R; Moore M; Burckin T; Truong L; Sasmor H; Levin AA
J Pharmacol Exp Ther; 2001 Mar; 296(3):898-904. PubMed ID: 11181922
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application.
Ghosh MK; Ghosh K; Dahl O; Cohen JS
Nucleic Acids Res; 1993 Dec; 21(24):5761-6. PubMed ID: 8284226
[TBL] [Abstract][Full Text] [Related]
7. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
[TBL] [Abstract][Full Text] [Related]
8. Selective binding of trisamine-modified phosphorothioate antisense DNA to target mRNA improves antisense activity and reduces toxicity.
Matsukura M; Okamoto T; Miike T; Sawai H; Shinozuka K
Biochem Biophys Res Commun; 2002 May; 293(5):1341-7. PubMed ID: 12054660
[TBL] [Abstract][Full Text] [Related]
9. Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNAse H cleavage of in vitro synthesized p120 mRNA.
Weidner DA; Busch H
Oncol Res; 1994; 6(6):237-42. PubMed ID: 7865899
[TBL] [Abstract][Full Text] [Related]
10. Targeting of antisense DNA: comparison of activity of anti-rabbit beta-globin oligodeoxyribonucleoside phosphorothioates with computer predictions of mRNA folding.
Jaroszewski JW; Syi JL; Ghosh M; Ghosh K; Cohen JS
Antisense Res Dev; 1993; 3(4):339-48. PubMed ID: 8155975
[TBL] [Abstract][Full Text] [Related]
11. Antisense recognition of the HER-2 mRNA: effects of phosphorothioate substitution and polyamines on DNA.RNA, RNA.RNA, and DNA.DNA duplex stability.
Venkiteswaran S; Vijayanathan V; Shirahata A; Thomas T; Thomas TJ
Biochemistry; 2005 Jan; 44(1):303-12. PubMed ID: 15628872
[TBL] [Abstract][Full Text] [Related]
12. Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.
Giles RV; Tidd DM
Anticancer Drug Des; 1992 Feb; 7(1):37-48. PubMed ID: 1311929
[TBL] [Abstract][Full Text] [Related]
13. Comparative inhibition of ras p21 protein synthesis with phosphorus-modified antisense oligonucleotides.
Chang EH; Yu Z; Shinozuka K; Zon G; Wilson WD; Strekowska A
Anticancer Drug Des; 1989 Oct; 4(3):221-32. PubMed ID: 2679622
[TBL] [Abstract][Full Text] [Related]
14. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
[TBL] [Abstract][Full Text] [Related]
15. Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides.
Cazenave C; Stein CA; Loreau N; Thuong NT; Neckers LM; Subasinghe C; Hélène C; Cohen JS; Toulmé JJ
Nucleic Acids Res; 1989 Jun; 17(11):4255-73. PubMed ID: 2472605
[TBL] [Abstract][Full Text] [Related]
16. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
Barker RH; Metelev V; Coakley A; Zamecnik P
Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
[TBL] [Abstract][Full Text] [Related]
18. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker.
Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
Aukunuru JV; Ayalasomayajula SP; Kompella UB
J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
